Patent ID: 9700564
Date: 2017-07-11
CPC Classifications: A61K,A61P,Y02A

Claim:
1. A method for treating a pulmonary infection in a human having cystic fibrosis, wherein the pulmonary infection comprises Pseudomonas aeruginosa , the method comprising: administering via inhalation 240 mg of levofloxacin twice daily for 28 days to the human having cystic fibrosis to treat the wherein the levofloxacin is in an aerosol of a solution comprising levofloxacin at a concentration from about 90 mg/ml to about 110 mg/ml, a magnesium cation at a concentration from about 175 mM to about 225 mM, wherein the solution has a pH from about 5 to about 7, and an osmolality from about 300 mOsmol/kg to about 500 mOsmol/kg.